Jordánia -
angol -
JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)
elocom ointment 0.1% 1 mg/gm
مستودع أدوية أداتكو - adatco drug store - mometasone furoate 1 mg/gm - 1 mg/gm
Jordánia -
angol -
JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)
proviron tab 25 mg
شركة مستودع الأدوية الأردني - the jordan drugstore co - mesterolone 25 mg - 25 mg
Jordánia -
angol -
JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)
sandostatin 100 mcg/ml solution for injection
شركة مستودع الأدوية الأردني - the jordan drugstore co - octreotide 100 mcg/ml - 100 mcg/ml
Izrael -
angol -
Ministry of Health
lenvima 10 mg
eisai israel ltd., israel - lenvatinib as mesilate - hard capsule - lenvatinib as mesilate 10 mg - lenvatinib - lenvima is indicated for the treatment of adult patients with progressive, locally advanced or metastatic, differentiated (papillary/follicular/hürthle cell) thyroid carcinoma (dtc), refractory to radioactive iodine (rai).lenvima is indicated in combination with everolimus for the treatment of adult patients with advanced clear cell renal cell carcinoma (rcc) following one prior vascular endothelial growth factor (vegf)-targeted therapy.lenvima is indicated as monotherapy for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma (hcc) who have received no prior systemic therapy.lenvima, in combination with pembrolizumab, is indicated for the treatment of adult patients with advanced or recurrent endometrial carcinoma who have disease progression on or following prior treatment with a platinum containing therapy and who are not candidates for curative surgery or radiation.lenvima is indicated in combination with pembrolizumab for the first-line treatment of adult patients with advanced rcc.
Izrael -
angol -
Ministry of Health
lenvima 4 mg
eisai israel ltd., israel - lenvatinib as mesilate - hard capsule - lenvatinib as mesilate 4 mg - lenvatinib - lenvima is indicated for the treatment of adult patients with progressive, locally advanced or metastatic, differentiated (papillary/follicular/hürthle cell) thyroid carcinoma (dtc), refractory to radioactive iodine (rai).lenvima is indicated in combination with everolimus for the treatment of adult patients with advanced clear cell renal cell carcinoma (rcc) following one prior vascular endothelial growth factor (vegf)-targeted therapy.lenvima is indicated as monotherapy for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma (hcc) who have received no prior systemic therapy.lenvima, in combination with pembrolizumab, is indicated for the treatment of adult patients with advanced or recurrent endometrial carcinoma who have disease progression on or following prior treatment with a platinum containing therapy and who are not candidates for curative surgery or radiation.lenvima is indicated in combination with pembrolizumab for the first-line treatment of adult patients with advanced rcc.
Jordánia -
angol -
JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)
klacid tab 500 mg
مستودع أدوية أبوشيخة - abu sheikha drug store - clarithromycin 500 mg - 500 mg
Jordánia -
angol -
JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)
klacid tab 500 mg
مستودع أدوية أبوشيخة - abu sheikha drug store - clarithromycin 500 mg - 500 mg
Jordánia -
angol -
JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)
klacid xl 500 mg
مستودع أدوية أبوشيخة - abu sheikha drug store - clarithromycin 500 mg - 500 mg
Jordánia -
angol -
JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)
klacid xl 500 mg
مستودع أدوية أبوشيخة - abu sheikha drug store - clarithromycin 500 mg - 500 mg
Jordánia -
angol -
JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)
marvelon tabs 0.030 mg, 0.15 mg
مستودع ادوية الصباغ - sabbagh drug store - ethinylestradiol 0.030 mg, desogestrel 0.15 mg - 0.030 mg, 0.15 mg